Landon Linda A, Zou Jun, Deutscher Susan L
Department of Biochemistry, M743 Medical Sciences Bldg., University of Missouri, Columbia, MO, USA.
Mol Divers. 2004;8(1):35-50. doi: 10.1023/b:modi.0000006897.40575.41.
The Thomsen-Friedenreich antigen, a carcinoma-associated disaccharide involved in carcinoma cell homotypic aggregation and increased metastatic potential, has clinical value as a prognostic indicator and a marker of metastasized cells. Hence, it can reasonably be predicted that antigen-binding macromolecules are valuable clinical in vivo diagnostic/therapeutic targeting agents. Recently, we have selected first-generation antigen-binding peptides from a random peptide bacteriophage display library and have applied combinatorial affinity maturation to select functionally-maturated peptides, which target cultured carcinoma cells and inhibit carcinoma cell aggregation. In the current study we hypothesize that a targeted search of sequence space surrounding the antigen-binding consensus sequence will select unpredictable amino acid sequences in the non-consensus portions of the peptides, leading to increased affinity for the carbohydrate and greater solubility in physiological buffers. This comprehensive in vitro analysis demonstrates that preferential evolution of the amino-terminal sequence of the peptides occurred, which correlated, in structure/function studies, with the acquisition of maturated function. The maturated peptides are more soluble than the earlier peptides. Studies of peptide binding to the disaccharide indicate that two maturated peptides (P-30-1, F03) have higher affinity for the antigen and bind with higher intensity to the surface of cultured human carcinoma cells than the first-generation peptides. The results support our hypothesis that affinity maturation can improve carbohydrate binding by peptides and have theoretical importance as the first report of maturation of carbohydrate-binding affinity in a small, soluble peptide.
汤姆森-弗里德赖希抗原是一种与癌细胞同型聚集及转移潜能增加相关的癌相关二糖,具有作为预后指标和转移细胞标志物的临床价值。因此,可以合理预测抗原结合大分子是有价值的临床体内诊断/治疗靶向剂。最近,我们从随机肽噬菌体展示文库中筛选出第一代抗原结合肽,并应用组合亲和力成熟技术来筛选功能成熟的肽,这些肽靶向培养的癌细胞并抑制癌细胞聚集。在本研究中,我们假设对抗原结合共有序列周围的序列空间进行靶向搜索将在肽的非共有部分中选择不可预测的氨基酸序列,从而导致对碳水化合物的亲和力增加以及在生理缓冲液中的溶解度提高。这种全面的体外分析表明,肽的氨基末端序列发生了优先进化,在结构/功能研究中,这与成熟功能的获得相关。成熟的肽比早期的肽更易溶解。肽与二糖结合的研究表明,两种成熟肽(P-30-1、F03)比第一代肽对抗原有更高的亲和力,并且与培养的人癌细胞表面的结合强度更高。这些结果支持了我们的假设,即亲和力成熟可以提高肽对碳水化合物的结合能力,并且作为关于小的可溶性肽中碳水化合物结合亲和力成熟的首次报道具有理论重要性。